Finance Home - My Yahoo - Yahoo! - Help

Friday, January 8, 2010, 2:06PM ET - U.S. Markets close in 1 hour and 54 minutes. Dow  0.28% Nasdaq  0.54%

Peregrine Pharmaceuticals Inc. (PPHM)

At 1:50PM ET: 3.11   0.11 (3.67%)

MORE ON PPHM

Quotes Summary Real-Time Options Historical Prices Charts Interactive Basic Chart Basic Tech. Analysis News & Info Headlines Financial Blogs Company Events Message Board Company Profile Key Statistics SEC Filings Competitors Industry Components Analyst Coverage Analyst Opinion Analyst Estimates Research Reports Star Analysts Ownership Major Holders Insider Transactions Insider Roster Financials Income Statement Balance Sheet Cash Flow

Headlines Get Headlines for:
Change Display [ hide $$  edit ] Wed, Jan 6, 2010 • Peregrine Pharmaceuticals to Present at the OneMedForum 2010 Finance Conference PR Newswire (Wed, Jan 6) Wed, Dec 16, 2009 • PEREGRINE PHARMACEUTICALS INC Financials EDGAR Online Financials (Wed, Dec 16) Sat, Dec 12, 2009 • New Star Analyst Rankings for Peregrine Pharmaceuticals Inc. StarMine (Sat, Dec 12) Thu, Dec 10, 2009 • PEREGRINE PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclo EDGAR Online (Thu, Dec 10) • Peregrine Pharmaceuticals Inc. F2Q10 (Qtr End 31/10/09) Earnings Call Transcript at Seeking Alpha (Thu, Dec 10) • Peregrine cuts 2Q loss nearly in half on revenue AP (Thu, Dec 10) • Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 PR Newswire (Thu, Dec 10) Thu, Dec 3, 2009 • Peregrine Pharmaceuticals to Report Second Quarter FY 2010 Financial Results PR Newswire (Thu, Dec 3) Wed, Dec 2, 2009 • Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial PR Newswire (Wed, Dec 2) Wed, Nov 18, 2009 • Peregrine Pharmaceuticals Presents Promising Antiviral Data at 2009 Chemical and Biological Defense Science & Technology Conference PR Newswire (Wed, Nov 18) Tue, Nov 10, 2009 • UBS Research Equity Analyst Picks Top Stocks In Large Cap Biotech Sector Wall Street Transcript (Tue, Nov 10) • New Study in Clinical Cancer Research Shows Therapeutic Promise of Peregrine's Bavituximab With Radiation in a Lethal Brain Cancer Model PR Newswire (Tue, Nov 10) Wed, Nov 4, 2009 • Peregrine Pharmaceuticals Awarded Second Broad U.S. Patent for Anti-Viral Applications of Phospholipid-Targeting Antibodies PR Newswire (Wed, Nov 4) Tue, Nov 3, 2009 • Peregrine Pharmaceuticals Regains Full Compliance With Nasdaq Continued Listing Requirements PR Newswire (Tue, Nov 3) Tue, Oct 27, 2009 • PEREGRINE PHARMACEUTICALS INC Files SEC form 8-K, Financial Statements and Exhibits EDGAR Online (Tue, Oct 27) • PEREGRINE PHARMACEUTICALS INC Files SEC form 8-K, Financial Statements and Exhibits EDGAR Online (Tue, Oct 27) Mon, Oct 26, 2009 • Trading Outlook for Peregrine Pharmaceuticals Issued by StockPreacher.com GlobeNewswire (Mon, Oct 26) Thu, Oct 22, 2009 • PEREGRINE PHARMACEUTICALS INC Financials EDGAR Online Financials (Thu, Oct 22) Wed, Oct 21, 2009 • Peregrine drug prompts response in cancer study AP (Wed, Oct 21) • Peregrine Pharmaceuticals Reports 61% Objective Response Rate in 46-Patient Bavituximab Phase II Trial in Advanced Breast Cancer PR Newswire (Wed, Oct 21) Older Headlines - Download Recent Headlines View headlines from: Wed, Oct 21, 2009Wed, Oct 14, 2009Wed, Oct 7, 2009Wed, Sep 30, 2009Wed, Sep 23, 2009Wed, Sep 16, 2009Wed, Sep 9, 2009Wed, Sep 2, 2009Wed, Aug 26, 2009Wed, Aug 19, 2009 Add PPHM News to My Yahoo!:
Add to Portfolio     Set Alert     Email to a Friend Get Headlines for Another Symbol: Symbol Lookup • Stocks In Play • Story Stocks • Full Coverage